InvestorsHub Logo
Followers 23
Posts 994
Boards Moderated 0
Alias Born 08/22/2013

Re: 1hb post# 320721

Wednesday, 08/26/2020 10:21:12 AM

Wednesday, August 26, 2020 10:21:12 AM

Post# of 403036
That’s Dr. William. He didn’t go to doctor school to be called Mister:)

DeGrado continued: “Although some defensins and other types of host defense peptides have been reported to be active against SARS-CoV-2, Brilacidin has the advantage of being a non-peptide—a synthetic, small molecule designed to be much more stable in the human body and its therapeutic properties optimized. Additionally, Brilacidin has progressed through Phase 2 clinical trials, including one in which it was administered orally for the treatment of Oral Mucositis. I am happy to advise Innovation Pharmaceuticals on the continuing development of Brilacidin for this indication, COVID-19, and other ongoing clinical applications.”

B for OM still on!
An anonymous emergency room dr. on a Message board may not see the value of B for OM but the Dr. who co-created it still does! Who are you going to believe?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News